Venture Medical Leads Investment in Plasmacure to Advance Breakthrough Cold Plasma Technology for Chronic Wound Healing
Summary
Venture Medical led a strategic investment in Plasmacure and joined a 6 million Series A round with several other investors. Plasmacure develops PLASOMA, a cold plasma therapy system for chronic wound healing. The company plans to use the funding to speed regulatory approval, reimbursement work, and U.S. expansion. Venture Medical also committed more than $10 million to support the product's rollout and market access efforts. The partnership aims to bring the wound-care technology to more clinicians and patients worldwide.
Funding
Amount
$6.0M
Total raised
Date
July 7, 2025
Announcement date
Investors
Noaber
Lead investors
Company
plasmacure.nl
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected